Article History
First Online: 30 March 2023
Competing interests
: D.P. receives licensing fees (to patents on which he was an inventor) from, invested in, consults for (or is on scientific advisory boards or boards of directors of), lectured to (and received a fee from) or conducts sponsored research at Tel Aviv University for the following entities: ART Biosciences, BioNTech SE, Eleven Therapeutics, Kernal Biologics, Merck, Newphase Ltd., NeoVac Ltd., RiboX Therapeutics, Roche, SirTLabs Corporation and Teva Pharmaceuticals Inc. The other authors declare no competing interests.